Egg oral immunotherapy in children (SEICAP I): Daily or weekly desensitization pattern

Autor: Martín-Muñoz MF, Belver MT, Alonso Lebrero E, Zapatero Remón L, Fuentes Aparicio V, Piquer-Gibert M, Plaza-Martín AM, Muñoz Román C, Martorell-Calatayud C, Martorell-Aragonés A, Blasco C, Vilá B, Gómez C, Nevot S, García Martinez JM, Madero Jarabo R, Echeverria L

Publikováno v: PEDIATRIC ALLERGY AND IMMUNOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu

BACKGROUND: Studies are required before incorporating egg oral immunotherapy (OIT) into clinical practice. The Spanish Society of Pediatric Allergy, Asthma and Clinical Immunology (SEICAP) conducted a multicenter, randomized controlled study assessin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::171028706069c6056cd2947760336314
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1382

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The impact of type 2 immunity and allergic diseases in atherosclerosis.

Autor: Fernández-Gallego N; Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain., Castillo-González R; Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Department of Pathology, Hospital 12 de Octubre, Madrid, Spain., Méndez-Barbero N; Vascular Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., López-Sanz C; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain., Obeso D; Department of Basic Medical Sciences, Faculty of Medicine, Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Chemistry and Biochemistry, Faculty of Pharmacy, Centre for Metabolomics and Bioanalysis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., Villaseñor A; Department of Basic Medical Sciences, Faculty of Medicine, Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Chemistry and Biochemistry, Faculty of Pharmacy, Centre for Metabolomics and Bioanalysis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., Escribese MM; Department of Basic Medical Sciences, Faculty of Medicine, Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., López-Melgar B; Department of Cardiology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Salamanca J; Department of Cardiology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Benedicto-Buendía A; Department of Cardiology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Jiménez-Borreguero LJ; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.; Department of Cardiology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Ibañez B; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.; Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Cardiology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Sastre J; Department of Allergy and Immunology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Belver MT; Department of Allergy, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Vega F; Department of Allergy, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Blanco C; Department of Allergy, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Barber D; Department of Basic Medical Sciences, Faculty of Medicine, Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., Sánchez-Madrid F; Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., de la Fuente H; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Martín P; Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Esteban V; Department of Allergy and Immunology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Faculty of Medicine and Biomedicine, Universidad Alfonso X El Sabio, Madrid, Spain., Jiménez-Saiz R; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB)-CSIC, Madrid, Spain.; Faculty of Experimental Sciences, Universidad Francisco de Vitoria (UFV), Madrid, Spain.; Department of Medicine, McMaster Immunology Research Centre (MIRC), McMaster University, Hamilton, Ontario, Canada.

Publikováno v: Allergy [Allergy] 2022 Nov; Vol. 77 (11), pp. 3249-3266. Date of Electronic Publication: 2022 Jul 18.

Protocol to prevent contrast-induced nephropathy in parenteral challenge tests for allergy evaluation of hypersensitivity reactions to iodinated contrast media.

Autor: Vega F; Department of Allergy, Instituto de Investigacion Sanitaria Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Múgica MV; Department of Allergy, Instituto de Investigacion Sanitaria Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Argíz L; Department of Allergy, Instituto de Investigacion Sanitaria Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Bazire R; Department of Allergy, Instituto de Investigacion Sanitaria Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Belver MT; Department of Allergy, Instituto de Investigacion Sanitaria Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Friera A; Department of Radiology, Instituto de Investigacion Sanitaria Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Blanco C; Department of Allergy, Instituto de Investigacion Sanitaria Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2020 Oct; Vol. 50 (10), pp. 1200-1203. Date of Electronic Publication: 2020 Jul 26.

Egg OIT in clinical practice (SEICAP II): Maintenance patterns and desensitization state after normalizing the diet.

Autor: Martín-Muñoz MF; Allergy Department, Pediatric Hospital La Paz (idiPaz), Madrid, Spain., Alonso Lebrero E; Allergy Department, Pediatric Hospital Gregorio Marañón, Madrid, Spain., Zapatero L; Allergy Department, Pediatric Hospital Gregorio Marañón, Madrid, Spain., Fuentes Aparicio V; Allergy Department, Pediatric Hospital Gregorio Marañón, Madrid, Spain., Piquer Gibert M; Allergy Section, Pediatric Hospital San Joan de Deu, Barcelona, Spain., Plaza Martín AM; Allergy Section, Pediatric Hospital San Joan de Deu, Barcelona, Spain., Muñoz C; Pediatric Allergy Section, Hospital Carlos Haya, Malaga, Spain., Belver MT; Allergy Department, Pediatric Hospital La Paz (idiPaz), Madrid, Spain., Martorell-Calatayud C; Allergy Department, General Hospital of Valencia, Valencia, Spain., Martorell-Aragonés A; Allergy Department, General Hospital of Valencia, Valencia, Spain., Blasco C; Allergy Department, Pediatric Hospital Vall d'Hebron, Barcelona, Spain., Vilá B; Allergy Department, Pediatric Hospital Vall d'Hebron, Barcelona, Spain., Gómez C; Allergy Department, Pediatric Hospital San Joan de Deu, Althaia, Manrresa, Spain., Nevot S; Allergy Department, Pediatric Hospital San Joan de Deu, Althaia, Manrresa, Spain., García Martín JM; Pediatric Allergy, Cruces Hospital, Bilbao, Spain., Madero R; Statistical Department, La Paz Hospital (idiPaz), Madrid, Spain., Echeverría L; Pediatric Allergy Section, Severo Ochoa Hospital, Madrid, Spain.

Publikováno v: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2019 Mar; Vol. 30 (2), pp. 214-224. Date of Electronic Publication: 2018 Dec 18.